Tepotinib in Solid Tumors Harboring MET Alterations

Clinical trial NCT04647838 · UNKNOWN

Trial details

NCT number: NCT04647838
Sponsor: Chungbuk National University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor MET Exon 14 Skipping Mutation MET Amplification

Start date: 2020-01-16
Primary completion: 2023-02-28
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.